Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2
Maik Friedrich, Gabriele Pfeifer, Stefanie Binder, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 19

Showing 19 citing articles:

Therapeutic siRNA: State-of-the-Art and Future Perspectives
Maik Friedrich, Achim Aigner
BioDrugs (2022) Vol. 36, Iss. 5, pp. 549-571
Open Access | Times Cited: 222
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access | Times Cited: 1
Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses
Beatrice Tolksdorf, Julian Heinze, Daniela Niemeyer, et al.
Antiviral Research (2024) Vol. 226, pp. 105879-105879
Open Access | Times Cited: 5
Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
Nina Geiger, Viktoria Diesendorf, Valeria Roll, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3972-3972
Open Access | Times Cited: 9
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
Helen Forgham, Aleksandr Käkinen, Ruirui Qiao, et al.
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 15
Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
Rushikesh Fopase, Chinmaya Panda, Amarnath P. Rajendran, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 8
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
Mouraya Hussein, Zaria Andrade dos Ramos, Monique Vink, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 686-686
Open Access | Times Cited: 8
XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection
Pehuén Pereyra Gerber, Maria J. Donde, Nicholas J. Matheson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
Viktoria Diesendorf, Valeria Roll, Nina Geiger, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Suppression of Interferon Response and Antiviral Strategies of Bunyaviruses
Yingying He, Min Shen, Xiaohe Wang, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 9, pp. 205-205
Open Access | Times Cited: 1
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
Qian Wang, Xing Wu, Qunying Mao, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1119-1127
Closed Access | Times Cited: 5
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
Élisabeth Houbron, Sophie Mockly, Sophia Rafasse, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 272-280
Open Access | Times Cited: 2
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms
Samir Mansour Moraes Casseb, André Salim Khayat, Jorge Estefano Santana de Souza, et al.
(2022)
Open Access | Times Cited: 4
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms
Samir Mansour Moraes Casseb, André Salim Khayat, Jorge Estefano Santana de Souza, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2147-2147
Open Access | Times Cited: 4
Target NF‐κB p65 for preventing posttraumatic joint contracture in rats
Lingpeng Kong, Yuqing Liang, Jing Hou, et al.
Journal of Orthopaedic Research® (2024) Vol. 42, Iss. 10, pp. 2172-2180
Closed Access
Forty years of HIV research inspires the development of SARS-CoV-2 therapy
Roberto Patarca, William A. Haseltine
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 1
A systematic analysis of anthocyanins inhibiting human, murine, and equine herpesviruses
Valeria Roll, Viktoria Diesendorf, Norbert Roewer, et al.
Phytomedicine (2023) Vol. 124, pp. 155314-155314
Closed Access | Times Cited: 1
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects
Abhilash Kannan, Maarit Suomalainen, Romain Volle, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1407-1407
Open Access | Times Cited: 1
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
Élisabeth Houbron, Sophie Mockly, Sophia Rafasse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top